Recombinant Human PMFBP1 Protein, N-His

Description of Recombinant Human PMFBP1 Protein, N-His

Introduction

Recombinant Human PMFBP1 Protein, also known as Platelet Mitochondrial Membrane Protein, is a recombinant protein that has been produced using genetic engineering techniques. This protein is an important antigen in the field of immunology and has various applications in both research and clinical settings. In this article, we will discuss the structure, activity, and applications of Recombinant Human PMFBP1 Protein.

Structure of Recombinant Human PMFBP1 Protein

Recombinant Human PMFBP1 Protein is a single-chain polypeptide consisting of 362 amino acids with a molecular weight of approximately 40 kDa. It is composed of two functional domains – an N-terminal mitochondrial targeting sequence and a C-terminal platelet-specific domain. The N-terminal mitochondrial targeting sequence is responsible for the localization of the protein to the mitochondria, while the C-terminal domain is responsible for its platelet-specific function.

Activity of Recombinant Human PMFBP1 Protein

Recombinant Human PMFBP1 Protein is primarily known for its role as an antigen in the immune response. It is expressed on the surface of platelets and is involved in the activation of platelets and the formation of blood clots. In addition, this protein has been found to play a role in the regulation of mitochondrial function and energy metabolism.

Studies have also shown that Recombinant Human PMFBP1 Protein has angiogenic activity, promoting the growth of new blood vessels. This activity is important in wound healing and tissue repair. Furthermore, this protein has been found to have anti-inflammatory properties, which may have potential therapeutic applications in various inflammatory diseases.

Applications of Recombinant Human PMFBP1 Protein

Recombinant Human PMFBP1 Protein has various applications in both research and clinical settings. In research, this protein is used as an antigen in studies related to platelet function and immune response. It is also used in studies related to mitochondrial function and energy metabolism.

In clinical settings, Recombinant Human PMFBP1 Protein has potential applications in the diagnosis and treatment of various diseases. Its role as an antigen makes it a potential biomarker for platelet-related disorders, such as thrombocytopenia and thrombosis. In addition, this protein’s angiogenic and anti-inflammatory properties make it a potential therapeutic target for wound healing and inflammatory diseases.

Furthermore, Recombinant Human PMFBP1 Protein has been used in the development of diagnostic tests for platelet function disorders. These tests can help in the early detection and diagnosis of platelet-related diseases, allowing for timely and effective treatment.

Conclusion

In conclusion, Recombinant Human PMFBP1 Protein is a single-chain polypeptide with a molecular weight of approximately 40 kDa. It is composed of two functional domains – an N-terminal mitochondrial targeting sequence and a C-terminal platelet-specific domain. This protein is primarily known for its role as an antigen in the immune response and has various applications in both research and clinical settings. Its potential as a biomarker and therapeutic target makes it a valuable protein in the field of immunology and platelet biology. Further research on this protein may uncover new insights into its structure and activity, leading to the development of novel diagnostic and therapeutic approaches.